Bluebird Bio Q3 Loss Narrows, Tops Estimates; Revenues Miss Estimates
(RTTNews) - Bluebird Bio, Inc. (BLUE) reported Tuesday a net loss for the third quarter of $71.73 million or $0.66 per share, narrower than $76.52 million or $0.94 per share in the prior-year quarter.
Total revenues for the quarter soared to $12.39 million from $0.01 million in the same quarter last year, primarily due to SKYSONA and ZYNTEGLO product revenue. On average, analysts polled by Thomson Reuters expected the company to report a loss of $0.67 per share on revenues of $13.41 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Bluebird Bio Says FDA Accepts BLA For Lovotibeglogene Autotemcel For Priority Review
bluebird bio, Inc. (BLUE) announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for lovotibeglogene autotemcel (lovo-cel) for priority review. The agency has set a Prescription Drug User Fee Act (PDUFA) goal date of December 20, 2023.
RTTNews
|
1187 days ago
U.S. Dollar Slips As Focus Shifts To Upcoming Trump's Meet With GCC Leaders
The U.S. Dollar value ticked lower on Friday after U.S. President Donald Trump hinted at returning to a possible military confrontation with Iran. Trump is planning to take a call after his upcoming meeting with the leaders of the Gulf Cooperation Council on Tuesday in New York.
RTTNews
|
1 day ago
Canadian Stocks Turning In Mixed Performance In Cautious Trade
Canadian stocks are turning in a mixed performance on Friday with investors largely making cautious moves, assessing geopolitical situation and weighing recent policy moves and inflation outlook from major central banks.
RTTNews
|
1 day ago
Swiss Market Ends On Weak Note
The Switzerland stock market closed notably lower on Friday, in line with markets across Europe as worries about inflation and uncertainty about central banks' monetary policy moves rendered the mood cautious.
RTTNews
|
1 day ago
European Stocks Fall As Central Bank Signals Weigh On Sentiment
European stocks declined Friday amid caution over monetary policy and inflation outlooks from major central banks. The ECB survey showed Euro Zone inflation expectations rose to 3% from 2.9%, while the Bank of Japan raised rates by 25 basis points.
RTTNews
|
1 day ago
U.S. Leading Economic Index Unexpectedly Edges Lower In August
A report released the Conference Board on Friday unexpectedly showed a modest decrease by its reading on leading U.S. economic indicators in the month of August. The Conference Board said its leading economic index edged down by 0.1 percent in August after rising by 0.2 percent in July. Economists had expected the index to inch up by 0.1 percent.
RTTNews
|
1 day ago
U.S. Industrial Production Unexpectedly Flat In August
With a jump in utilities output offset by a decrease in manufacturing output, the Federal Reserve released a report on Friday showing U.S. industrial production unexpectedly came in flat in the month of August. The Fed said industrial production was unchanged in August after rising by an unrevised 0.2 percent in July. Economists had expected industrial production to climb by 0.3 percent.
RTTNews
|
1 day ago
UK Retail Sales Recover Unexpectedly
UK retail sales rebounded unexpectedly in August underpinned by online shopping and warm weather boosted sales of seasonal items, data from the Office for National Statistics revealed Friday. Retail sales grew 0.5 percent on a monthly basis, offsetting July's 0.5 percent fall. Sales were expected to drop 0.2 percent.
RTTNews
|
2 days ago
